Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Background Why alcohol-associated liver disease (ALD) resolves after abstinence in most people but progresses to liver ...

Fatty acids derived from palm oil and coconut oil are found in countless everyday products, but their extraction drives deforestation. Researchers at ...

Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.70 target price on Theralase ...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...

The findings show that prolonged targeted therapy in patients with head and neck cancer can heighten tumor alertness, ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet rewires liver cells and makes them more prone to becoming cancerous. The ...

The holiday season is about spending time with loved ones, which also means hearing all of the random words and phrases the young ones have picked up since you saw them last year. No thanks to the ...